Ticker Scorecard - MYGN Basics Company: Myriad Genetics, Inc. IPO Date: October 6, 1995 Sector: Healthcare Industry: Biotech Market Cap: $1.29B Activated in VL: True Average Daily Range Avg Daily Range: $0.51 | 1.87% Avg Daily Range (30 D): $0.38 | 2.85% Avg Daily Range (90 D): $0.41 | 2.51% Institutional Daily Volume Avg Daily Volume: .97M Avg Daily Volume (30 D): .91M Avg Daily Volume (90 D): .78M Trade Size Avg Trade Size (Sh.): 146 Avg Trade Size (Sh.) (30 D): 72 Avg Trade Size (Sh.) (90 D): 68 Institutional Trades Total Inst.Trades: 11,496 Avg Inst. Trade: $1.86M Avg Inst. Trade (30 D): $1.81M Avg Inst. Trade (90 D): $2.21M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.54M Avg Closing Trade (30 D): $2.19M Avg Closing Trade (90 D): $2.69M Avg Closing Volume: 100.23K     News Feb 18, 2025 @ 11:30 PM Pancreatic Cancer Diagnostic Market to Reach $3.2 ... Source: Allied Market Research Jan 27, 2025 @ 2:57 AM Myria and Beacher’s Madhouse to Bring an Un... Source: N/A Jan 23, 2025 @ 10:42 AM Predictive Genetic Testing and Consumer Genomics M... Source: Researchandmarkets.Com Jan 20, 2025 @ 3:35 PM Cancer Biopsy Market Size is Expected to Reach USD... Source: Straits Research Jan 9, 2025 @ 9:30 PM Myriad Genetics Signs Agreement with Nationally Re... Source: N/A Financials   TTM Q3 2024 Q2 2024 Basic EPS $-1.28 $-.24 $-.41 Diluted EPS $-1.28 $-.24 $-.41 Revenue $ 823.6M $ 213.3M $ 211.5M Gross Profit $ $ 149.8M $ 147.1M Net Income / Loss $ -116M $ -22.1M $ -36.7M Operating Income / Loss $ -115.8M $ -20M $ -36.5M Cost of Revenue $ $ 63.5M $ 64.4M Net Cash Flow $ 24.8M $ 6.3M $ -2.1M PE Ratio     Splits Mar 26, 2009:   1:2 Sep 12, 2000:   1:2